Jennifer Taubert, EVP, WW Chair, Pharmaceuticals at Johnson & Johnson (NYSE:JNJ), executed a sale of 59,397 shares in the company on February 9, 2024, according to a recent SEC filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles